Sources | Names Used |
---|---|
GDSC1000 | QL-VIII-58 |
PharmacoGx | QL-VIII-58 |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | SSR3 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | FEV | GDSC1000 | pan-cancer | AAC | -0.14 | 0.01 |
mRNA | KCNK3 | GDSC1000 | pan-cancer | AAC | -0.13 | 0.01 |
mRNA | KRTAP5-10 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | SLC34A3 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | HRG | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | NPFFR2 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.01 |
mRNA | ABL1 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | C10orf82 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
mRNA | CHMP7 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.01 |